About our collaborators:

• Mike Tansey

• Yinong Young-Xu Corey May

• FDA Development and use of risk minimization plans.

• FDA Premarketing risk assessment.

• FDA Good pharmacovigilance practices and pharmacoepidemiologic assessment.

• EMEA July 4th 2003 Head of Agencies Meeting.

• FDA 1999 Risk Management Framework.

• CERTS.

• ICH E2E.

• ISPE.

• Pharmaceutical Medicine & Drug Development Program, UNSW, Australia.

Home
About Us
Databases
Epidemiology
Pharmacovigilance
Research & Development
Services
Publications
Contact
Related Links